American CryoStem Corporation Sustainability Profile
American CryoStem Corporation, headquartered in the United States, is a pioneering entity in the regenerative medicine and biotechnology industry. Founded in 2008, the company has established itself as a leader in the field of adipose-derived stem cell technology, focusing on the development and commercialisation of innovative cellular therapies. With a strong presence across major operational regions in North America, American CryoStem offers unique services such as stem cell banking and processing, which are designed to harness the potential of adipose tissue for therapeutic applications. Their commitment to quality and safety has positioned them as a trusted provider in the market, achieving notable milestones in research and product development. As a key player in the regenerative medicine sector, American CryoStem continues to advance the science of stem cell therapy, contributing to the evolving landscape of healthcare solutions.
DitchCarbon Score
How does American CryoStem Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
American CryoStem Corporation's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
American CryoStem Corporation's reported carbon emissions
American CryoStem Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that American CryoStem Corporation may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.
How Carbon Intensive is American CryoStem Corporation's Industry?
How Carbon Intensive is American CryoStem Corporation's Location?
American CryoStem Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
American CryoStem Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
